WS18.04 Change in markers of systemic inflammation after elexacaftor/tezacaftor/ivacaftor initiation: results from 18 months follow-up in the Danish cystic fibrosis cohort

Autor: Bryrup, T., Olsen, M.F., Pressler, T., Jeppesen, M., Fangel-Jensen, S., Olesen, H.V., Skov, M., Qvist, T., Faurholt-Jepsen, D.
Zdroj: In Journal of Cystic Fibrosis June 2023 22 Supplement 2:S34-S34
Databáze: ScienceDirect
Externí odkaz: